The facility is expected to produce small-molecule medicines targeting cardiometabolic conditions, cancer, immune disorders and neurological diseases
The quality chasm between manufacturing and compounding done at a pharmacist level is still quite wide and quite varied, said Kastango
But weighing the two, seeing thousands of patients over this period of time, they really start to embrace the disease concept because for them it puts together oh, now I understand why it is so difficult for me to reduce my calories long term and keep my weight off
Unlike the majority of wellness brands operating on white-label infrastructure, Neurogan maintains its own in-house laboratory, a full-time staff chemist, and HPLC testing protocols across its product line
Microdosing GLP-1 uses the smallest measurements on your syringe
The Nrf2-HO-1 system and inflammaging